Combined Effects of Prunus Cerasus and Apocynum Venetum On Sleep and Anxiety in Adults With Insomnia - Trial NCT06299488
Access comprehensive clinical trial information for NCT06299488 through Pure Global AI's free database. This phase not specified trial is sponsored by Lakshmi Nutraceuticals LLC and is currently Completed. The study focuses on Insomnia. Target enrollment is 77 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Lakshmi Nutraceuticals LLC
Timeline & Enrollment
N/A
Apr 05, 2023
Jul 01, 2023
Primary Outcome
Subjective Sleep Quality
Summary
Lay Summary: This study is about the effect of using a unique formula called Sip2Sleep®, a
 product currently available on the market which is a combination of montmorency tart cherry
 extract and Venetron® (Apocynum venetum leaf extract) on sleep. The purpose of this study is
 to evaluate the effects of taking this combination product on various aspects of sleep. This
 study is being conducted by People Science, and is sponsored by Lakshmi Nutraceuticals, LLC.
 The information we gather will help inform how people may use Sip2Sleep® to affect the
 quality of sleep.
 
 Participants in this study will complete a number of surveys about their difficulties falling
 asleep and staying asleep (insomnia), their energy level during the day and health status
 regarding their quality of sleep.
 
 There are no major risks associated with this study.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06299488
Non-Device Trial